BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Basmisanil readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Basmisanil\, from ClinicalTrials.gov esti
 mates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07846215-9396@assetmemo.bio
DTSTAMP:20261121T004554Z
DTSTART;VALUE=DATE:20290501
DTEND;VALUE=DATE:20290502
SUMMARY:Basmisanil: Phase 2 readout est. (NCT07846215)
DESCRIPTION:Basmisanil\, phase 2.\nStudy: A Phase II Study of Basmisanil in
  Children and Adolescents With Dup15q Syndrome\nEstimated primary completi
 on: 1 May 2029. This is a ClinicalTrials.gov estimate\, not a confirmed re
 adout date\, and it can move.\nDrug page: https://assetmemo.bio/drug/basmi
 sanil#upcoming-events\nRegistry record: https://clinicaltrials.gov/study/N
 CT07846215
URL:https://assetmemo.bio/drug/basmisanil#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
